PAR 12.7% 31.0¢ paradigm biopharmaceuticals limited..

Valuation and Targets, page-341

  1. 4,214 Posts.
    lightbulb Created with Sketch. 6699
    Eire2011...yes a very valid point you make...its better that we dont partner up too early... and I would think PAR are adequately aware of this...PR did make mention of this at the last AGM...we are in a position of power to choose...not the other way around.

    PharmD...I wouldn't want to venture a global figure..it would be potentially too big to fit on my 8 digit calculator...rolleyes.png

    AS Eire2011 reminds us in his last post, we may only get a royalty cut (20%? Maybe 25% if we are v lucky)..it would still be a crazy figure. If you still want to pursue this line of thought have a read of 51Cap's material, they allude to what these figs could be one day...yes it might be a good 8 to 10 years away...but quite possible.




    Last edited by Mozzarc: 07/04/20
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.